Skip to content

Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours

Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00260416
Enrollment
60
Registered
2005-12-01
Start date
2005-05-31
Completion date
2007-12-31
Last updated
2008-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Acute myocardial infarction, Symptom duration, Primary angioplasty, Infarct size, Myocardial scintigraphy

Brief summary

Background: Acute balloon angioplasty is beneficial in patients with acute myocardial infarction. However, presently this treatment is not offered to patients with symptom duration above 12 hours. Hypothesis: Acute balloon angioplasty for myocardial infarction is beneficial despite symptom duration above 12 hours. Methods: In 60 patients with myocardial infarction and symptom duration above 12 hours, the proportion of non-perfused myocardium before acute angioplasty and 1 month after angioplasty is compared to evaluate if myocardial tissue can be saved by acute angioplasty despite long symptom duration.

Detailed description

Methods: On arrival at our angioplasty laboratory, patients are informed about the study. If they accept to participate, we infuse 600 MBq of Sestamibi i.v. This binds in a first passage fashion without later redistribution to perfused myocardium. Non-perfused myocardium does not bind sestamibi. Primary angioplasty with stent and abciximab is then performed followed by myocardial scintigraphy to illustrate the non-perfused myocardial area that was at risk of infarction before the coronary artery was opened. Echocardiography is also performed. At 1 month, myocardial scintigraphy is repeated to evaluate infarct size. The difference between the myocardial area at risk of infarction before angioplasty and the myocardial infarct size 1 month later is defined as salvage. Scintigraphy is repeated at 6 month and echocardiography is also repeated at 1 month and 6 months. The primary endpoint is salvage. Accordingly, the aim is to demonstrate that salvage can be achieved with primary angioplasty for acute myocardial infarction despite symptom duration above 12 hours. Clinical endpoints are death and reinfarction. The results are compared with results in 200 patients with symptom duration below 12 hours. These patients are treated and examined according to the exact same protocol. By this comparison, it can be evaluated whether it is relevant that the current guidelines recommend acute balloon angioplasty only to patients with less than 12 hours of symptom duration.

Interventions

PROCEDUREPrimary angioplasty with stent and abciximab

Sponsors

Danish Heart Foundation
CollaboratorOTHER
Aarhus University Hospital Skejby
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute myocardial infarction with ST-segment elevation; * Symptom duration 12 hours to 72 hours.

Exclusion criteria

* Age below 18 years; * Bleeding disorders or anaemia or low levels of thrombocytes; * Thrombolysis used during the present admission; * Expected survival less than 1 year due to other diseases; * Previous acute myocardial infarction or coronary by-pass surgery; * Major operation within last 30 days; * Heamorrhaghic stroke within last 3 months.

Design outcomes

Primary

MeasureTime frame
Myocardial salvage as evaluated by repeat myocardial scintigraphy(= area at risk of infarction before primary angioplasty - infarct size at 1 month).

Secondary

MeasureTime frame
Death at 1 month and 6 months.
Reinfarction at 1 month and 6 months.
Infarct size by myocardial scintigraphy at 1 month and 6 months after primary angioplasty.
Left ventricular end diastolic volume at 1 day, 1 month and 6 months.
Brain Natriuretic Peptide levels at 1 day, 1 month and 6 months.
Ejection fraction at 1 day, 1 month and 6 months.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026